TUBERCULOSIS TRENDS IN HIV-INFECTED PATIENTS IN THE CISCOUNTRIES IN 2014-2018


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To estimate tuberculosis (TB) morbidity and mortality rates in the general population and HIV-infected patients in six CIS countries (Azerbaijan, Armenia, Belarus, Kyrgyzstan, Tajikistan, and Uzbekistan) and in the Vladimir Region (the Russian Federation) in 2014-2018. Materials and methods. National statistics, as well as materials of the countries’ regular reporting to the WHO and UNAIDS were used as main sources. Results. All of the above participating countries showed a reduction in TB morbidity and mortality rates during the study period. The TB morbidity rates in HIV patients (per 100,000patients) were significantly higher than those in the general population of Azerbaijan and Armenia (by 19.2 and 134.7 times greater, respectively). Among the HIV-infected patients who died from secondary diseases, the number of TB deaths was minimal in the Republic of Belarus (16.3%) and in the Vladimir Region (21.4%). In the other participating countries, TB was the cause of death in nearly half of HIV-infected patients (49.2-54.2%). Conclusion. Despite a clear trend towards the decrease in TB mortality rates in the CIS countries, the problem of HIV/TB co-infection is undoubtedly of relevance in this region.

Full Text

Restricted Access

About the authors

Alexey V. KRAVCHENKO

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: alexey-kravtchenko@yandex.ru
Prof., MD, Leading Researcher Moscow, Russia

Anastasia V. POKROVSKAYA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: pokrovskaya_av@mail.ru
Cand. Med. Sci., Senior Researcher Moscow, Russia

Ekaterina I. KULABUKHOVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Peoples' Friendship University of Russia

Email: ekulabukhova@mail.ru
Infectiologist, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Head, Laboratory of the Department of Infectious Diseases with Courses of Epidemiology and Phthisiology, Medical Institute, Peoples’ Friendship University of Russia Moscow, Russia

Vera N. ZIMINA

Peoples' Friendship University of Russia

Email: vera-zim@yandex.ru
MD, Professor, Department of Infectious Diseases with Courses of Epidemiology and Phthisiology, Medical Institute Moscow, Russia

Zoya K. SUVOROVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: zksu@inbox.ru
Cand. Biol. Sci., Senior Researcher Moscow, Russia

Olga N. KHOKHLOVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: x.olia79@mail.ru
Cand. Med. Sci., Laboratory Doctor Moscow, Russia

Ekaterina A. LI

Autonomous Nonprofit Organization «Center for Advanced Technologies in Healthcare»

Email: kh.yekaterina@gmail.com
Head, Research Program Supervisor Moscow, Russia

Tatiana N. ZAMKOVAYA

Regional Center for AIDS Prevention and Control, Vladimir Regional Clinical Hospital

Email: aids.doctor@yandex.ru
aids.doctor@yandex.ru Vladimir, Russia

Agigat A.-K. KADYROVA

Research Institute of Lung Diseases, Ministry of Health of the Azerbaijan Republic

Email: dr.kadyrovah@mail.ru
Prof., MD, Director Baku, Azerbaijan

Arshak S. PAPOYAN

Republican Center for AIDS Prevention, Ministry of Health of the Republic of Armenia

Email: arshak.papoyan1@gmail.com
Epidemiologist Yerevan, Armenia

Tamara N. SVETOGOR

Republican Center for Hygiene, Epidemiology, and Public Health

Email: svetogor_tamara@mail.ru
Epidemiologist; Head, Department for Prevention of HIV Infection and Parenteral Viral Hepatitides Minsk, Republic of Belarus

Alijon A. SOLIEV

Republican AIDS Center, Ministry of Health of the Kyrgyz Republic

Email: salijon@mail.ru
Cand. Med. Sci., Deputy Director Bishkek, Kyrgyzstan

Aibek A. BEKBOLOTOV

Republican Center for AIDS Prevention and Control, Ministry of Health and Social Protection of the Population of the Republic of Tajikistan

Email: aibek_0001@mail.ru
Deputy Director Dushanbe, Tajikistan

Mubarak Yu. BEKMETOVA

Republican Center for AIDS Control, Ministry of Health of the Republic of Uzbekistan

Email: yuldashovna@mail.ru
Highest Category Infectiologist; Head, Polyclinic Tashkent, Uzbekistan

Vadim V. POKROVSKY

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: pokrovsky.vad@yandex.ru
Prof., Academician of the Russian Academy of Sciences MD, Head, HIV Department Moscow, Russia

References

  1. WHO. End TB strategy (Electronic resource). 2015. https:// www.who.int/tb/post2015_strategy/en/
  2. van Hest N.A., Aldridge R.W., de Vries G., Sandgren A., Hauer B., Hayward A. et al. Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill. 2014; 19(9): pii 20728. https://doi. org/10.2807/1560-7917.ES2014.19.9.20728
  3. Tankimovich M. Barriers to and Interventions for Improved Tuberculosis Detection and Treatment among Homeless and Immigrant Populations: A Literature Review. J. Community Health Nurs 2013; 30 (2): 83-95. doi: 10.1080/ 07370016.2013.778723
  4. Fenner L., Egger M., Bodmer T., Furrer H., Ballif M., Battegay M. et al. HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis. PLoS Genet. 2013; 9(3): e1003318.https://doi.org/10.1371/journal. pgen.1003318
  5. European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2019-2017 data. Copenhagen: WHO Regional Office for Europe, 2019. https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe -2019#no -link
  6. Dye C., Bassili A., Bierrenbach A.L., Broekmans J.F., Chadha V.K., Glaziou P. et al. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet. Infect. Dis. 2008; 8(4): 233-43. doi: 10.1016/S1473-3099(07)70291-8
  7. Glaziou P., Dodd P.J., Zignol M., Sismanidis C., Floyd K. Methods used by WHO to estimate the global burden of TB disease. 2019. https://www. who.int/tb/publications/global_ report/tb19_technical_appendix.pdf
  8. Naghavi M. et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1151-210. doi: 10.1016/S0140-6736(17)32152-9
  9. World Health Organization. WHO TB burden estimates. WHO’s global tuberculosis database. https://www.who.int/tb/ country/data/download/en/
  10. Mikkelsen L., Phillips D.E., AbouZahr C., Setel P.W., de Savigny D., Lozano R. et al. A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet 2015; 386(10001): 1395-406. doi: 10.1016/ S0140-6736(15)60171-4
  11. Phillips D.E., Lozano R., Naghavi M., Atkinson C., Gonzalez-Medina D., Mikkelsen L. et al. A composite metric for assessing data on mortality and causes of death: The vital statistics performance index. Popul Health Metr. 2014; 12: 14. doi: 10.1186/1478-7954-12-14
  12. Global tuberculosis report 2018. World Health Organization, 2018. 231 p.
  13. Реализация стратегии ликвидации туберкулеза: основные положения. Женева: Всемирная организация здравоохранения, 2018. 113 c.
  14. Use of high burden country lists for TB by WHO in the post-2015 era. World Health Organization, 2015. 15 p.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies